Drug Profile
Prednimustine
Alternative Names: LEO 1031; Mostarina; NSC 134087; Sterecyt; StereocytLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antineoplastics; Nitrogen mustard compounds; Pregnadienetriols
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Cancer in USA (PO)
- 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
- 27 Jan 1995 Launched for Cancer in Austria (PO)